400 related articles for article (PubMed ID: 23656173)
1. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
[TBL] [Abstract][Full Text] [Related]
2. Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury.
Zhang Y; Chopp M; Meng Y; Zhang ZG; Doppler E; Winter S; Schallert T; Mahmood A; Xiong Y
J Neurosurg; 2015 Apr; 122(4):843-55. PubMed ID: 25614944
[TBL] [Abstract][Full Text] [Related]
3. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
Guekht AB; Moessler H; Novak PH; Gusev EI;
J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
[No Abstract] [Full Text] [Related]
5. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
[TBL] [Abstract][Full Text] [Related]
6. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
Theadom A; Mahon S; Barker-Collo S; McPherson K; Rush E; Vandal AC; Feigin VL
Eur J Neurol; 2013 Aug; 20(8):1135-44. PubMed ID: 23384428
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.
Zhang Y; Chopp M; Gang Zhang Z; Zhang Y; Zhang L; Lu M; Zhang T; Winter S; Brandstätter H; Mahmood A; Xiong Y
J Neurosurg; 2018 Nov; 129(5):1295-1304. PubMed ID: 29303438
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.
Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H
J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744
[TBL] [Abstract][Full Text] [Related]
9. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
[TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
Lang W; Stadler CH; Poljakovic Z; Fleet D;
Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
[TBL] [Abstract][Full Text] [Related]
13. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study.
Muresanu DF; Alvarez XA; Moessler H; Novak PH; Stan A; Buzoianu A; Bajenaru O; Popescu BO
J Neurol Sci; 2010 Dec; 299(1-2):179-83. PubMed ID: 20923712
[TBL] [Abstract][Full Text] [Related]
14. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration.
Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO
J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059
[TBL] [Abstract][Full Text] [Related]
15. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.
Panisset M; Gauthier S; Moessler H; Windisch M;
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1089-104. PubMed ID: 12111446
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
[TBL] [Abstract][Full Text] [Related]
17. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
19. [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)].
Damulin IV; Koberskaia NN; Mkhitarian EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):32-8. PubMed ID: 18379494
[TBL] [Abstract][Full Text] [Related]
20. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
